摘要
Manoela FASSINA 医师
医学博士
Post-Subcision Hyperpigmentation: Clinical Management and Treatment
Objectives: To present effective clinical strategies for managing post-subcision hyperpigmentation, particularly hemosiderin-induced and post-inflammatory cases. This session aims to provide medical colleagues with practical tools for early prevention, multimodal treatments, and case-based protocols to improve outcomes and reduce patient dissatisfaction following cellulite subcision procedures.
Introduction: Post-subcision hyperpigmentation is a common concern in aesthetic dermatology, especially in patients with prolonged bruising. Hemosiderin staining and post-inflammatory pigmentation may persist for months. Understanding the pathophysiology and risk factors is essential to optimize prevention and implement individualized treatment plans.
Materials / method: This presentation is based on clinical experience from over 300 subcision cases treated for cellulite. A protocol combining preventive oral tranexamic acid, early carboxytherapy, topical depigmenting agents, microneedling with drug delivery, and selective laser technologies was implemented. Cases of chronic pigmentation received targeted escalation with thioglycolic acid and picosecond laser.
Results: Over 80% of patients showed partial or complete improvement of pigmentation within 3 to 6 months. Early intervention and adherence to the combined protocol significantly reduced chronic pigmentation. Persistent cases responded well to individualized escalation therapy, with minimal adverse effects. Patient satisfaction improved notably with proactive pigment management.
Conclusion: Post-subcision pigmentation can be effectively managed through multimodal, protocol-driven care. Early intervention, combined with proper patient selection and ongoing monitoring, enhances treatment success. Clinical outcomes reinforce the importance of personalized strategies that integrate topical, systemic, and energy-based therapies to address pigmentation at different depths and etiologies.
披露 - Manoela FASSINA
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2026年 4月 28日 - Recorded during IMCAS World Congress 2026